ITJ Chief Technology Officer Mark Field [Photo courtesy of Insulet]
“As I step into this exciting new chapter, I want to express my deep gratitude for six amazing years at Insulet, where I had the honor of serving as CTO and helping lead the development of Omnipod 5 — one of the most impactful and successful medical devices in history,” Field said on LinkedIn. “I’m incredibly proud of what we accomplished together and feel fortunate to have been part of a mission-driven team improving the lives of people with diabetes every day.”
“To the entire Insulet family, thank you for the experience of a lifetime,” he continued. “I’ll always cheer you on as you continue to build upon groundbreaking technology and expand your impact around the world.”
Related: Diabetes device developers turn their sights to type 2
Field, who discussed Insulet’s cross-border recruiting of engineers from Mexico for Omnipod 5 at DeviceTalks West 2023, left Insulet last month. The diabetes tech developer and manufacturer is the world’s 57th-largest medical device company, according to Medical Design & Outsourcing‘s 2024 Medtech Big 100 ranking by revenue.
ITJ is headquartered in Rancho Santa Fe, California, and has a center of excellence in Tijuana, Mexico. The company called Field a “highly respected leader in healthcare and life sciences, known for driving innovation and leading global teams across some of the industry’s most transformative companies.”
“His expertise will strengthen our commitment to delivering excellence, advancing our technology vision, and supporting our clients through high-impact nearshore solutions,” the company said on LinkedIn. “At ITJ, we believe in building with the best — and Mark’s arrival reflects our ongoing dedication to bringing world-class leadership to help our partners scale and innovate.”
Field said he’s “thrilled by the opportunity to help many more companies accelerate their innovation programs — while also creating meaningful, high-impact jobs for talented engineers across Latin America.”
“It’s truly a dream role, and I can’t wait for what’s ahead,” he said.
Read more: Six tips for outsourcing, nearshoring and no-shoring from medtech vet Mark Field
